DK1970059T3 - Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser - Google Patents

Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser

Info

Publication number
DK1970059T3
DK1970059T3 DK07005084T DK07005084T DK1970059T3 DK 1970059 T3 DK1970059 T3 DK 1970059T3 DK 07005084 T DK07005084 T DK 07005084T DK 07005084 T DK07005084 T DK 07005084T DK 1970059 T3 DK1970059 T3 DK 1970059T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
drug
treatment
calcium dobesilate
tendon disorders
Prior art date
Application number
DK07005084T
Other languages
English (en)
Inventor
Gerhard Dr Stuker
Christian Fricker
Original Assignee
Dobavet Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dobavet Gmbh filed Critical Dobavet Gmbh
Application granted granted Critical
Publication of DK1970059T3 publication Critical patent/DK1970059T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
DK07005084T 2007-03-12 2007-03-12 Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser DK1970059T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07005084A EP1970059B1 (de) 2007-03-12 2007-03-12 Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen

Publications (1)

Publication Number Publication Date
DK1970059T3 true DK1970059T3 (da) 2009-12-21

Family

ID=38294171

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07005084T DK1970059T3 (da) 2007-03-12 2007-03-12 Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser

Country Status (6)

Country Link
US (1) US20080223379A1 (da)
EP (1) EP1970059B1 (da)
AT (1) ATE449602T1 (da)
CA (1) CA2621332A1 (da)
DE (1) DE502007002101D1 (da)
DK (1) DK1970059T3 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
JP2008522642A (ja) 2004-10-06 2008-07-03 ガイデッド セラピー システムズ， エル．エル．シー． 美容強化のための方法およびシステム
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
EP3682946A1 (en) 2004-10-06 2020-07-22 Guided Therapy Systems, L.L.C. System for noninvasive tissue treatment
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
JP2010526589A (ja) 2007-05-07 2010-08-05 ガイデッド セラピー システムズ， エル．エル．シー． 音響エネルギーを使用してメディカントを調節するための方法およびシステム
US20150174388A1 (en) 2007-05-07 2015-06-25 Guided Therapy Systems, Llc Methods and Systems for Ultrasound Assisted Delivery of a Medicant to Tissue
KR102479936B1 (ko) 2008-06-06 2022-12-22 얼테라, 인크 초음파 치료 시스템
WO2010075547A2 (en) 2008-12-24 2010-07-01 Guided Therapy Systems, Llc Methods and systems for fat reduction and/or cellulite treatment
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US9149658B2 (en) 2010-08-02 2015-10-06 Guided Therapy Systems, Llc Systems and methods for ultrasound treatment
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
WO2013009784A2 (en) 2011-07-10 2013-01-17 Guided Therapy Systems, Llc Systems and method for accelerating healing of implanted material and/or native tissue
WO2013012641A1 (en) 2011-07-11 2013-01-24 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
CN204637350U (zh) 2013-03-08 2015-09-16 奥赛拉公司 美学成像与处理系统、多焦点处理系统和执行美容过程的系统
US10561862B2 (en) 2013-03-15 2020-02-18 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
FR3019820B1 (fr) * 2014-04-15 2017-07-21 Peter Weyts Composes de type flavonoides pour leur utilisation dans le traitement d'une pathologie du pied d'un mammifere ongule-composition pharmaceutique associee
CA3177417A1 (en) 2014-04-18 2015-10-22 Ulthera, Inc. Band transducer ultrasound therapy
MX2018007094A (es) 2016-01-18 2018-11-09 Ulthera Inc Dispositivo de ultrasonido compacto que tiene un arreglo de ultrasonido anular perifericamente conectado electricamente a una placa de circuito impreso flexible y un metodo de montaje del mismo.
CN114631846A (zh) 2016-08-16 2022-06-17 奥赛拉公司 用于皮肤的美容超声治疗的系统和方法
WO2019164836A1 (en) 2018-02-20 2019-08-29 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679372A5 (da) * 1989-04-07 1992-02-14 Vet Gerhard Stuker Dr Med
CH682716A5 (de) * 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.

Also Published As

Publication number Publication date
EP1970059A1 (de) 2008-09-17
ATE449602T1 (de) 2009-12-15
US20080223379A1 (en) 2008-09-18
EP1970059B1 (de) 2009-11-25
CA2621332A1 (en) 2008-09-12
DE502007002101D1 (de) 2010-01-07

Similar Documents

Publication Publication Date Title
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
DK1957061T3 (da) Kombination omfattende mindst én aminosyre og en PKR-inhibitor til anvendelse i behandlingen af muskelsvind
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
MY172012A (en) Use of dpp iv inhibitors
EA200901339A1 (ru) Ороназофарингеально доставляемая фармацевтическая композиция агонистов дофамина для предупреждения/облегчения и/или лечения расстройств беспокойных конечностей
ATE453642T1 (de) Substituierte phenylaminopyrimidine
EA200971053A1 (ru) Способы лечения кожных язв
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
EA201200428A1 (ru) Композиция и способ для лечения ожирения
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
MX2008002456A (es) Uso de ambroxol para el tratamiento de infecciones por rinovirus.
EP1844779A3 (de) Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne)
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
NO20073104L (no) Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure